BACKGROUND: Lung cancer screening in high-risk population increases the proportion of patients diagnosed at a resectable stage. AIMS: To optimize the selection criteria and quality indicators for lung cancer screening by low-dose CT (LDCT) in the Czech population of high-risk individuals. To compare the influence of screening on the stage of lung cancer at the time of the diagnosis with the stage distribution in an unscreened population. To estimate the impact on life-years lost according to the stage-specific cancer survival and stage distribution in the screened population. To calculate the cost-effectiveness of the screening program. METHODS: Based on the evidence from large national trials - the National Lung Screening Trial in the USA (NLST), the NELSON study, the recent recommendations of the Fleischner society, the American College of Radiology, and I-ELCAP action group, we developed a protocol for a single-arm prospective study in the Czech Republic for the screening of high-risk asymptomatic individuals. The study commenced in August 2020. RESULTS: The inclusion criteria are: age 55 to 74 years; smoking: ≥30 pack-years; smoker or ex-smoker <15 years; performance status (0-1). The screening timepoints are at baseline and 1 year. The LDCT acquisition has a target CTDIvol ≤0.5mGy and effective dose ≤0.2mSv for a standard-size patient. The interpretation of findings is primarily based on nodule volumetry, volume doubling time (and related risk of malignancy). The management includes follow-up LDCT, contrast enhanced CT, PET/CT, tissue sampling. The primary outcome is the number of cancers detected at a resectable stage, secondary outcomes include the average cost per diagnosis of lung cancer, the number, cost, complications of secondary examinations, and the number of potentially important secondary findings. CONCLUSIONS: A study protocol for early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE) study using LDCT has been described.

1st Department of Tuberculosis and Respiratory Diseases

Department of Anesthesiology and Intensive Care 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Radiology

Institute of Nuclear Medicine

Zobrazit více v PubMed

Novotvary | UZIS CR. https://www.uzis.cz/category/tematicke-rady/zdravotnicka-statistika/novotvary. Accessed June 6, 2019.

Cornfield J, Haenszel W, Hammond EC, et al. Smoking and lung cancer: recent evidence and a discussion of some questions. Int J Epidemiol 2009;38:1175–91. PubMed

Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer. Open Biol 2017;7:170070. PubMed PMC

Aberle DR, Adams AM, et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409. PubMed PMC

de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503–13. PubMed

MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017. Radiology 2017;284:228–43. PubMed

McKee BJ, Regis SM, McKee AB, et al. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2015;12:273–6. PubMed

Henschke CI, Li K, Yip R, et al. The importance of the regimen of screening in maximizing the benefit and minimizing the harms. Ann Transl Med 2016;4:1–3. PubMed PMC

Jang S, Graffy PM, Ziemlewicz TJ, et al. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology 2019;291:360–7. PubMed PMC

Pickhardt PJ, Pooler BD, Lauder T, et al. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 2013;158:588–95. PubMed PMC

Iersel CA van, Koning HJ de, Draisma G, et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868–74. PubMed

Field JK, Duffy SW, Baldwin DR, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess Winch Engl 2016;20:1–46. PubMed PMC

Kauczor H-U, Bonomo L, Gaga M, et al. ESR/ERS white paper on lung cancer screening. Eur Radiol 2015;25:2519–31. PubMed PMC

Snowsill T, Yang H, Griffin E, et al. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. Health Technol Assess Winch Engl 2018;22:1–276. PubMed PMC

Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. CHEST 2018;153:954–85. PubMed

Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet 2012;3:268. PubMed PMC

Trujillo-Reyes JC, Seijo L, Martínez-Tellez E, et al. Lung cancer screening, what has changed after the latest evidence? World J Radiol 2020;12:130–6. PubMed PMC

Gierada DS, Black WC, Chiles C, et al. Low-dose CT screening for lung cancer: evidence from 2 decades of study. Radiol Imaging Cancer 2020;2:e190058. PubMed PMC

Calabrò E, Randi G, Vecchia CL, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J 2010;35:146–51. PubMed

Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296–301. PubMed

Yousaf-Khan U, Aalst C van der, Jong PA de, et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 2017;72:48–56. PubMed

Huber A, Landau J, Ebner L, et al. Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging. Eur Radiol 2016;26:3643–52. PubMed

Messerli M, Kluckert T, Knitel M, et al. Computer-aided detection (CAD) of solid pulmonary nodules in chest x-ray equivalent ultralow dose chest CT - first in-vivo results at dose levels of 0.13 mSv. Eur J Radiol 2016;85:2217–24. PubMed

Tammemagi M, Ritchie AJ, Atkar-Khattra S, et al. Predicting malignancy risk of screen-detected lung nodules–mean diameter or volume. J Thorac Oncol 2019;14:203–11. PubMed

Loverdos K, Fotiadis A, Kontogianni C, et al. Lung nodules: a comprehensive review on current approach and management. Ann Thorac Med 2019;14:226–38. PubMed PMC

Larici AR, Farchione A, Franchi P, et al. Lung nodules: size still matters. Eur Respir Rev 2017;26:170025. PubMed PMC

McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910–9. PubMed PMC

The National Lung Screening Trial Research Team. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980–91. PubMed PMC

Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332–41. PubMed

Callister MEJ, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE. Thorax 2015;70:ii1–54. PubMed

Heuvelmans MA, Vliegenthart R, de Koning HJ, et al. Quantification of growth patterns of screen-detected lung cancers: the NELSON study. Lung Cancer 2017;108:48–54. PubMed

Zhao YR, Xie X, de Koning HJ, et al. NELSON lung cancer screening study. Cancer Imaging 2011;11:S79–84. PubMed PMC

Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177–84. PubMed

Walter JE, Heuvelmans MA, Yousaf-Khan U, et al. New subsolid pulmonary nodules in lung cancer screening: the NELSON Trial. J Thorac Oncol 2018;13:1410–4. PubMed

Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. Am J Roentgenol 2002;178:1053–7. PubMed

Heuvelmans MA, Walter JE, Oudkerk M. Management of baseline and new sub-solid nodules in CT lung cancer screening. Expert Rev Respir Med 2018;12:1–3. PubMed